The researchers found that the bioabsorbable occluder was non-inferior to the metallic occluder for ASD closure, with success rates of 96.5% and 97.4%, respectively, suggesting a possible new option for ASD closure.
Fortunately, this complication, called the Eisenmenger syndrome, usually develops over many years and occurs only in a small percentage of people with large atrial septal defects.